Regulatory strategy in the F&F industry is a multi-market, multi-framework discipline requiring simultaneous management of FDA GRAS notifications, EU flavoring substance approvals, IFRA compliance, China CFSA registration, and a dozen other national and regional frameworks — each operating on different timelines with different evidence requirements.
The cost and complexity of global regulatory compliance is increasing. The EU’s ongoing review of Union List flavoring substances is removing approved ingredients and creating reformulation requirements. IFRA’s 51st Amendment has restricted materials widely used in fragrance formulations. FDA’s scrutiny of GRAS self-affirmations has intensified. Together these changes favor large suppliers with dedicated regulatory affairs teams.
This report focuses on regulatory strategy — not regulatory compliance — recognizing that the most effective regulatory programs are those that anticipate changes, engage proactively with regulatory bodies, and turn regulatory expertise into competitive advantage.
FDA GRAS Strategy — Self-affirmation vs. notification decisions. FEMA GRAS and its role in the U.S. flavor industry. Building GRAS dossiers for new ingredients. Managing FDA review program risk.
EU Flavor Regulatory Strategy — Union List management, EFSA engagement, and proactive approach to substance review. Preparing for Union List deletions and their commercial implications.
IFRA Compliance Strategy — Managing the IFRA amendment cycle. Proactive reformulation ahead of effective dates. Communicating IFRA compliance status to FMCG customers.
China CFSA Registration — New substance notification, existing substance registration, and the timeline and resource requirements for Chinese market access.
Novel Food and Novel Ingredient Pathways — EU Novel Food Regulation, FDA food additive petition, and the regulatory pathways for genuinely new flavor and fragrance ingredients including biotech-derived molecules.
Global Registration Strategy — Market entry sequencing, regulatory resource planning, and the build vs. outsource decision for regulatory affairs capability.
Table of Contents
1. Executive Summary
2. Market Overview
3. Global F&F Regulatory Landscape
4. FDA GRAS Strategy
5. EU Flavor Regulatory Strategy
6. IFRA Compliance Strategy
7. China CFSA Registration
8. Novel Food and Novel Ingredient Pathways
9. Global Registration Strategy
10. Competitive Landscape
11. Strategic Conclusions and Recommendations
12. Appendix
List of Tables
Table 1. Global F&F Regulatory Frameworks — Key Requirements and Timelines 2025
Table 2. FDA GRAS — Self-Affirmation vs. Notification Decision Framework
Table 3. EU Union List — Recent Deletions and Pending Reviews 2025
Table 4. IFRA 51st Amendment — Key Restrictions and Reformulation Requirements
Table 5. China CFSA — Registration Requirements and Timeline Analysis 2025
Table 6. Novel Food and Novel Ingredient Pathways — Comparison by Market 2025
Table 7. Biotech-Derived Ingredient Regulatory Classification — Key Markets 2025
Table 8. Global Registration Strategy — Market Entry Sequencing Framework
Table 9. Leading Suppliers — Regulatory Affairs Capability and Investment 2025
Table 10. Key Risks and Mitigation Strategies
Companies Profiled
DSM-Firmenich
Givaudan
IFF
Mane
Robertet
Sensient
Symrise
T. Hasegawa
Takasago
